What did @tomo_marjanovic actually say?
The video features AJ Sims (@cementfactory) making several claims about hormone optimization, medical education, and the limits of diet and exercise. The core argument: "You can never out-diet bad hormones. You can never out-cardio bad hormones." Sims also claims that bodybuilders "know more about health" than most doctors, that medical education on nutrition is nearly nonexistent, and that "Big pharma will teach you how to mask" health issues rather than fix them. Blood work is presented as the foundation of any serious health approach.
For context, this is a podcast clip being promoted to an audience clearly interested in TRT and hormone optimization. The framing positions the medical establishment as ignorant and the fitness/hormone optimization community as the real experts. That framing deserves scrutiny, even when some underlying points have merit.
Does the science back this up?
Partially. The claim that hormones significantly affect body composition and metabolic function is well-supported. The claim that doctors are comprehensively ignorant and bodybuilders are comprehensively better informed is not.
On hormones and body composition: hypogonadism, subclinical hypothyroidism, and insulin resistance each independently impair fat loss and muscle retention regardless of caloric deficit or exercise volume. A 2013 study by Finkelstein et al. in the New England Journal of Medicine demonstrated that testosterone deficiency directly reduced muscle mass and increased fat mass even when activity levels were controlled. So the spirit of "bad hormones limit results" has real biological grounding.
On medical nutrition education: a 2015 survey by Crowley et al. in the Journal of Biomedical Education found that only 27% of U.S. medical schools met the minimum 25 hours of nutrition education recommended by the National Academy of Sciences. That is a real and documented gap. Sims is not wrong here.
On bodybuilders knowing more than doctors: this is where the logic breaks down. Anecdotal expertise in one area does not transfer cleanly to clinical judgment, pharmacology, or differential diagnosis. The risks of unsupervised supraphysiological hormone use are also well-documented, and those risks are rarely part of the bodybuilding knowledge base.
What did they get wrong (or right)?
They got the core physiology directionally right but oversold it into an absolute. "You can never out-cardio bad hormones" is a rhetorical overclaim. Lifestyle intervention absolutely moves hormones. A 2016 meta-analysis by Hackney et al. in Current Sports Medicine Reports confirmed that consistent aerobic exercise raises testosterone in sedentary and moderately active men. Resistance training elevates growth hormone acutely. Sleep extension raises luteinizing hormone. These are not trivial effects.
What Sims likely means, in charitable reading, is that severe hormonal dysfunction, meaning clinical hypogonadism or significant thyroid disease, cannot be fully compensated by lifestyle alone. That is accurate. But "bad hormones" is doing a lot of heavy lifting in that sentence. The phrase blurs the line between clinically deficient and suboptimally optimized, a distinction that matters enormously when someone is deciding whether they need TRT or better sleep habits.
The dismissal of the medical system as just masking symptoms is also a broad overreach. It has rhetorical appeal in this community but ignores the substantial evidence base behind standard-of-care endocrinology.
What should you actually know?
If your hormone levels are clinically low, diet and exercise are unlikely to fully correct them, and that is a legitimate reason to talk to a physician. Finkelstein et al. (2013, NEJM) and other controlled trials support the idea that hormonal status shapes body composition outcomes even when calories and training are equated.
However, "hormone optimization" as a concept sits in a much grayer zone than clinical hormone replacement. There is limited high-quality randomized trial data supporting the use of TRT in men with low-normal testosterone who do not meet diagnostic criteria for hypogonadism. The Testosterone Trials (Snyder et al., 2016, NEJM) showed benefits in older men with confirmed low testosterone, but the findings do not automatically extend to younger men seeking performance optimization.
Blood work matters. Sims is right that labs are foundational. But interpreting them requires clinical context, not just raw numbers. Reference ranges, symptoms, and risk factors all interact. A number on a panel is not a prescription.
Finally, the framing that bodybuilders are better health educators than physicians is dangerous if it causes someone to delay diagnosis of a real pathology. Elevated testosterone can mask serious conditions. Suppression from exogenous androgens can cause lasting fertility and pituitary consequences. Those are not masking strategies from Big Pharma. They are documented physiological risks.